SLBT
SL Science Holding Limited (NASDAQ)
Healthcare — Biotechnology
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. The company is based in Taipei, Taiwan.
None
$4.40
$-0.05 (-1.12%)
Sign in to add SLBT to a watchlist or set price alerts.
Price History
52-Week Range
Fundamentals
| Market Cap | $2.47B |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-0.01 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 34.5 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $14.50 |
| 52-Week Low | $3.00 |
| 50-Day Avg | $7.90 |
| 200-Day Avg | $9.45 |
| Avg Volume | 709.1K |
| Volume | 3.8K |
Performance Analysis
NEUTRALSLBT presents a mixed picture with both positive and negative indicators.
~
Trading at 12% of its 52-week range.
~
RSI at 34.5 is in neutral territory.
-
Price is below both the 50-day and 200-day moving averages — in a downtrend.
~
Wall Street consensus is "none".
Recent News
Loading news...
Last updated: Jul 02, 2026 13:31 UTC
Back to Screener Export Report